United Therapeutics Corporation
↗Silver Spring, Maryland, United States
United Therapeutics is a publicly traded biotechnology company focused on creating innovative pharmaceutical therapies and technologies for patients with chronic and life-threatening illnesses. Founded in 1996 by Martine Rothblatt, the company pioneered treatments for pulmonary arterial hypertension (PAH) and has expanded into organ transplantation, xenotransplantation, and other rare disease areas. United Therapeutics operates as a public benefit corporation and maintains a significant presence in drug development, manufacturing (through subsidiary Unither Pharmaceuticals), and bioelectronics for organ delivery.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Rare Disease Therapeutics, Organ Transplantation, Xenotransplantation
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$3.18B (2025)
Founded:1996
Ownership:public
Status:operating
FUNDING
Stage:Public Company
STOCK
Exchange:NASDAQ
Ticker:UTHR
Market Cap:$22.9B
PIPELINE
Stage:Phase 1-3 and Commercial
Lead Drug Stage:Commercial (Tyvaso DPI, Remodulin, Orenitram)
Modalities:Small molecule, Inhaled therapeutics, Injectable treatments, Bioengineered organs, Xenotransplantation
Active Trials:1
Trial Phases:Phase 1: 1 | Phase 3: 1
FDA Approvals:6
CORPORATE STRUCTURE
Subsidiaries:Unither Pharmaceuticals (CDMO for sterile liquid pharmaceuticals), Unither Bioelectronics Inc., Unither Bioelectronique
Key Partnerships:MannKind (Tyvaso DPI intellectual property licensing), Liquidia Corporation (competitive treprostinil products), Multiple pharmaceutical manufacturers and CDMOs for contract manufacturing
COMPETITION
Position:Leader
Competitors:Gilead Sciences, Vertex Pharmaceuticals, Incyte, Novartis, Merck (Winrevair - sotatercept for PAH), Liquidia Technologies (Yutrepia - treprostinil), ACADIA Pharmaceuticals, Onyx Pharmaceuticals +1 more
LEADERSHIP
Key Executives:
Dr. Martine Rothblatt - Founder, Chairperson & CEO
James C. Edgemond - Chief Financial Officer & Treasurer
Michael Benkowitz - President/Chief Operating Officer
Alyssa Friedrich - Senior Vice President, Human Resources & Corporate Development
Liang Guo - Executive Vice President, Chemistry R&D and Production
Scientific Founders:Dr. Martine Rothblatt (Founder, focused on orphan diseases)
Board Members:Martine Rothblatt (Chairperson), Jan Malcolm (elected 2024)
LINKS
Website:unither.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of United Therapeutics Corporation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with United Therapeutics Corporation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.